SCHEMBL9429707

SCHEMBL9429707

COc1cc2c(cc1OC)C(COc1ccc(C=C3SC(=O)NC3=O)cc1)C2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 1/20 0.59
PIM1 P11309 5/20 0.58
PIM2 Q9P1W9 5/20 0.58
PIM3 Q86V86 2/20 0.57
PDE4B Q07343 1/20 0.57
HPGD P15428 5/20 0.56
AKR1B1 P15121 1/20 0.55
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
ESRRA P11474 2/20 0.55
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
FOXM1 Q08050 1/20 0.52
GSK3B P49841 2/20 0.51
CDC7 O00311 1/20 0.51
DAPK3 O43293 1/20 0.51
DYRK3 O43781 1/20 0.51
MAP4K4 O95819 1/20 0.51
PHKG2 P15735 1/20 0.51
RPS6KB1 P23443 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9429827 0.82 HPGD (0.61) IGF1RPIM1PIM2HPGD
SCHEMBL9429040 0.82 PYGL (0.56) PIM1PIM2HPGDGSK3B
SCHEMBL9311363 0.82 ALDH1A1 (0.46) HPGDRAB9AMEN1KMT2A
SCHEMBL9312842 0.81 HPGD (0.61) PIM1PIM2HPGDAKR1B1
SCHEMBL1299479 0.75 PIM1 (1.00) IGF1RPIM1PIM2PIM3HPGD
SCHEMBL2546354 0.75 PIM1 (1.00) IGF1RPIM1PIM2PIM3HPGD
SCHEMBL1299480 0.75 PIM1 (1.00) IGF1RPIM1PIM2PIM3HPGD
SCHEMBL2424658 0.74 PDE4B (1.00) IGF1RPIM1PIM2PIM3PDE4B
SCHEMBL31521577 0.74 PDE4B (1.00) IGF1RPIM1PIM2PIM3PDE4B
SCHEMBL15421515 0.74 PDE4B (1.00) IGF1RPIM1PIM2PIM3PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5330999-A Diabetes, obesity ADIR ET COMPAGNIE (FR) 1994-07-19 US disclosed
US-5266582-A Antidiabetic agents ADIR ET COMPAGNIE (FR) 1993-11-30 US disclosed
EP-0528734-A1 Thiazolidin-2,4-dione derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1993-02-24 EP disclosed